Optomind Inc., II-VI Incorporated, MACOM and MultiLane SAL Collaborate to Demonstrate 200G QSFP56 AOC at OFC 2019
The Optical Networking and Communication Conference & Exhibition 2019 (OFC 2019), San Diego Convention Center, CA, March 5-7, 2019: Optomind Inc. will be demonstrating 200-Gbit/s (200G) quad small form factor pluggable (QSFP) 56 AOC at the OFC 2019 (Booth #4507, MultiLane). Optomind Inc. has been working closely with II-VI Incorporated, MACOM and MultiLane SAL for this demonstration.
Advancing from 100G to 400G drastically transforms the ecosystem of data centers and data center interconnects. With 100G in wide scale deployment today and 400G not yet at mainstream cost structures, Cloud Data Centers are eager to take advantage of any and every opportunity to bridge the throughput gap and keep pace with the demand for data. The 200G short reach AOC is now applicable to high-end AI server as well as high performance computing (HPC), and serves as an intermediate between 100G and 400G.
II-VI’s 8-element VCSEL arrays can be modulated at 28 Gb/s using non-return to zero (NRZ) or at 56 Gb/s using 4-level pulse amplitude modulation (PAM4) to achieve a combined 200 or 400 Gb/s respectively over short reach multimode links.
Leveraging MACOM’s four channel 53Gbps PAM4 Analog CDR, linear TIA and VCSEL driver chip-set, Optomind’s optical engine technology enables a 200G QSFP56 AOC to operate for 100 m OM3 multimode fiber which includes optimal architecture design to enhance signal integrity at receiver by employing a custom plastic injection mold and an exclusive optical assembly.
Optomind promises a timely delivery of high quality AOCs in a large volume at the most affordable price on the market. Customer sampling of new 200G QSFP56 AOCs will begin during the third quarter this year. Acquiring short reach in-connectivity solution for hyperscale data center top-of-rack (ToR) interconnect between switch and server by means of high-density form factors: QSFPD-DD and OSFP will be the next step for Optomind.
To address the needs of the evolving data center MultiLane has developed a variety of test solutions that can characterize the high speed optical and electrical interfaces from 10G to 400G. At OFC MultiLane will demonstrate its new ML1016D-CR 53 GBaud PAM4 Optical Clock Recovery module for 100G Lambda testing.
About Optomind Inc.
Optomind Inc. is a global leader in development and cost-effective mass production of advanced active optical cable (AOC), offering the finest optical interconnect solutions to both data center and non-data center applications.
About II-VI Incorporated
II-VI Incorporated, a global leader in engineered materials and optoelectronic components, is a vertically integrated manufacturing company that develops innovative products for diversified applications in the industrial, optical communications, military, life sciences, semiconductor equipment, and consumer markets. The Company produces a wide variety of application-specific photonic and electronic materials and components, and deploys them in various forms, including integrated with advanced software to support our customers.
MACOM enables a better-connected and safer world by delivering breakthrough semiconductor technologies for optical, wireless and satellite networks that satisfy society’s insatiable demand for information. MACOM is a pillar of the semiconductor industry, thriving for more than 60 years of daring to change the world for the better, through bold technological strokes that deliver true competitive advantage to customers and superior value to investors. MACOM has design centers and sales offices throughout North America, Europe and Asia.
About MultiLane SAL
MultiLane Inc. develops instruments and interconnect test modules for 10 to 400 Gb/s data rates. Products include BERTs, TDR, optical and electrical scopes, and a host of MSA-compliant development tools for CFP, CFP2, QSFP, QSFP-DD, and OSFP modules. The company also offers compliance test services and fully automated test solutions. MultiLane’s products are used to test semiconductors, AOCs, DACs, electro-optical modules, and blades.
Media contact: Yung Sung Son at email@example.com, 408-782-4506
About II-VI Incorporated
Media contact: Mark Lourie at firstname.lastname@example.org
Media Contact: Ozzie Billimoria, email@example.com
Media contact: Kees Propstra at firstname.lastname@example.org, 510-738-9484
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Life-Sciences and Healthcare Communications Leaders John “Zeke” Czekanski and Scott Roberts Join Citrus Global Healthcare Communications Group as Managing Partners21.3.2019 14:21:00 CET | Pressemelding
Industry leaders John “Zeke” Czekanski and Scott Roberts have joined Citrus Global Healthcare Communications Group as Managing Partners. Zeke will oversee Citrus Scientific while Scott brings his extensive global market access and value experience in guiding Citrus Access. Together they will actively co-manage Citrus Strategy, providing insights enabling clients to innovate with confidence, broaden opportunities, and drive meaningful human-health outcomes forward. “I’m thrilled to be part of the Citrus Group working in partnership with our clients, the medical community, payers, government agencies, and global healthcare stakeholders. We look forward to delivering meaningful scientific insights and market-access solutions,” commented Zeke. Scott added, “There is a critical need in our industry, especially with highly innovative small to mid-size life-science companies, for a transformational agency applying data and analytics along with a holistic approach to the communications continu
Abzena Announces New Fully Integrated Developability and Optimization Service to Improve Lead Selection and De-risk Biologic Cell Line Development21.3.2019 13:44:00 CET | Pressemelding
Abzena, the leading biologics target to GMP partner research organisation (PRO), announced its Cambridge UK site has brought together its extensive discovery, immunogenicity assessment, protein engineering, formulation, bioassay and analytical expertise to launch a developability assessment and optimization service to assist customers in selecting and developing the best lead candidate to take forward for manufacture. The new Developability Service reduces the time, risk and cost required to take multiple lead candidates through cell line development and manufacturing. Biologics have potential liabilities for safety, functionality, stability and scalability and when these issues are identified early alternate leads can be selected, liabilities engineered out or measures can be taken to mitigate risk. The Developability Service also enables the selection of drug candidates most aligned with the target product profile by evaluating a range of functionality and specificity readouts. The s
XPRIZE Identifies 10 Future Breakthroughs Required to Protect Our Forests21.3.2019 13:27:00 CET | Pressemelding
Today, on the United Nations’ International Day of Forests, XPRIZE is releasing the Future of Forests Impact Roadmap, created in partnership with Kimberly-Clark Corporation. The digital report and its interactive website, based on future foresight techniques, illustrate the breakthroughs required for a healthier forest ecosystem, which might be the basis of future XPRIZE competitions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190321005409/en/ Across the world, forests provide food security and shelter, protect biodiversity and house indigenous populations. While forests cover more than 30 percent of the Earth’s surface, more than 32 million acres of forests are lost due to human activity every year, with research showing that continued mass deforestation and degradation is accelerating climate change. XPRIZE designs and operates global competitions to incentivize the development of technological breakthroughs that accel
Mark Thorne Joins BCW as Global Chief Financial Officer and Chief Operating Officer21.3.2019 13:17:00 CET | Pressemelding
BCW (Burson Cohn & Wolfe), a leading global communications agency, announced today that Mark Thorne has been appointed Global Chief Financial Officer and Chief Operating Officer, effective immediately. Thorne will be a strategic partner to BCW Global CEO Donna Imperato in transforming the agency’s financial model to better reflect its wide range of services and offerings. He is based in New York and replaces Pat Przybyski, formerly Global Chief Financial Officer. “Mark is well known for his strong business acumen, deep operational experience and high-level strategic thinking,” said Imperato. “I have known Mark for many years and am thrilled to now call him my partner. He is the right leader to help BCW execute our strategies and grow exponentially.” Thorne spent the past 20 plus years with Hill+Knowlton Strategies in a range of leadership roles, most recently serving as Global Chief Financial Officer and Global Chief Operating Officer. Prior to that, Thorne was Executive Vice President
Imago BioSciences Announces $40 Million Series B Financing Led by Omega Funds21.3.2019 13:09:00 CET | Pressemelding
Imago BioSciences, Inc., a clinical-stage biotechnology company developing innovative treatments for myeloid diseases, today announced a $40 million Series B financing led by Omega Funds, a leading international investment firm that creates and invests in life sciences companies. Other investors participating in the round include existing investors Frazier Healthcare Partners, Amgen Ventures, and MRL Ventures Fund as well as HighLight Capital, Pharmaron and Greenspring Associates. Dr. Dina Chaya from Omega Funds will join the board of directors and Dennis Henner will remain Chairman of the Board, representing his fund. “Imago BioSciences is extremely gratified with the interest and support of the investment community; we are particularly pleased with the composition of this new investment syndicate,” said Hugh Young Rienhoff, Jr. M.D., CEO at Imago BioSciences. “These funds will enable Imago to advance our programs through the completion of Phase 2b studies.” “We are excited to work wi
Workiva Wins DevOps Excellence Award in London21.3.2019 13:03:00 CET | Pressemelding
Workiva (NYSE:WK), the leading cloud provider of connected data, reporting and compliance solutions, today announced that its Wdesk platform was named the Best Software-Defined Product, last night at Computing's DevOps Excellence Awards dinner. The Computing DevOps Excellence Awards recognize outstanding achievement from organisations, personalities and solutions operating within the DevOps industry. Winners were selected on their superior functionality, level of ability to modernize business processes, positive customer feedback and a strong return on investment. “We are proud to win this prestigious award,” said Marty Vanderploeg, CEO of Workiva. “As the global leader in connected reporting, XBRL and Inline XBRL, our Wdesk platform helps customers all over the world consolidate, connect and tag their data in a single, cloud environment so they are able to reduce risk and save time when filing reports with various regulators and other stakeholders.” XBRL (eXtensible Business Reporting